Ravi Panchmatia

Ravi Panchmatia, MBA, CPA, currently serves as the Head of FP&A at Voyager Therapeutics, Inc., following a tenure at Mural Oncology as Head of Financial Planning Analysis. Prior experience includes leadership roles such as Head of Commercial Finance at Alkermes, where responsibilities encompassed P&L oversight for the global commercial business, and Head of Neurodegeneration Finance at Biogen, supporting pre-commercial launch and lifecycle management. Ravi also directed finance activities at PAREXEL and served as a Senior Finance Manager at Boston Scientific, providing strategic financial support. Additional experience includes positions at PwC, Ernst & Young, and EMC Corporation. Educational credentials consist of an MBA in Finance from Bentley University, a Master of Commerce in Accounting/Taxation from the University of Mumbai, and a Bachelor of Commerce in Accounting/Taxation from Narsee Monjee College of Commerce and Economics.